Vaccine hesitancy: the next challenge in the fight against COVID-19.
Amiel A. Dror,Netanel Eisenbach,Shahar Taiber,Nicole G. Morozov,Matti Mizrachi,Asaf Zigron,Samer Srouji,Eyal Sela +7 more
TLDR
It is indicated that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to CO VID-19 vaccination if and when available, and parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy.Abstract:
Vaccine hesitancy remains a barrier to full population inoculation against highly infectious diseases. Coincident with the rapid developments of COVID-19 vaccines globally, concerns about the safety of such a vaccine could contribute to vaccine hesitancy. We analyzed 1941 anonymous questionnaires completed by healthcare workers and members of the general Israeli population, regarding acceptance of a potential COVID-19 vaccine. Our results indicate that healthcare staff involved in the care of COVID-19 positive patients, and individuals considering themselves at risk of disease, were more likely to self-report acquiescence to COVID-19 vaccination if and when available. In contrast, parents, nurses, and medical workers not caring for SARS-CoV-2 positive patients expressed higher levels of vaccine hesitancy. Interventional educational campaigns targeted towards populations at risk of vaccine hesitancy are therefore urgently needed to combat misinformation and avoid low inoculation rates.read more
Citations
More filters
Journal ArticleDOI
Perceptions, knowledge and attitudes about COVID-19 vaccine hesitancy in older Portuguese adults
TL;DR: In this article , the authors assess the major factors associated with VHR in the older population in Portugal through computer assisted telephone interviews and determine the adjusted odds ratio (OR) of the independent variables (perceptions, knowledge and attitudes) and of the outcome (VHR).
Journal ArticleDOI
Coronavirus disease 2019 vaccine acceptance and perceived barriers among university students in northeast Ethiopia: A cross-sectional study.
Birhan Tsegaw Taye,Fetene Kasahun Amogne,Tesfanesh Lemma Demisse,Mulualem Silesh Zerihun,Tebabere Moltot Kitaw,Agumas Eskezia Tiguh,Muhabaw Shumye Mihret,Azmeraw Ambachew Kebede +7 more
TL;DR: In this article, a cross-sectional study was conducted in January 2021 at Debre Berhan University among 423 students, where a semi-structured, pretested, and self-administered questionnaire was used to collect the data and a multivariable logistic regression model was fitted to identify factors associated with vaccine acceptance.
Journal ArticleDOI
Factors Associated with Healthcare Workers' (HCWs) Acceptance of COVID-19 Vaccinations and Indications of a Role Model towards Population Vaccinations from a Cross-Sectional Survey in Greece, May 2021.
Konstantinos Fotiadis,Katerina Dadouli,Ioanna Avakian,Zacharoula Bogogiannidou,Varvara A. Mouchtouri,Konstantinos Gogosis,Matthaios Speletas,Michalis Koureas,Eleni Lagoudaki,Sofia Kokkini,Emmanouil Bolikas,Vasilios Diamantopoulos,Athanasios Tzimitreas,Christos Papadopoulos,Evangelia Farmaki,Antonis Sofos,Maria Giovanna Chini,Maria Tsolia,Vassiliki Papaevangelou,Evangelia E. Ntzani,Evangelia E. Ntzani,Achilleas Gikas,Panagiotis Prezerakos,Christos Hadjichristodoulou +23 more
TL;DR: A Knowledge, Attitudes and Practices (KAP) study was conducted at the end of May 2021 engaging 1456 healthcare workers (HCWs) from 20 hospitals throughout Greece as mentioned in this paper.
Posted ContentDOI
COVID19 vaccine intentions in South Africa: health communication strategy to address vaccine hesitancy
TL;DR: The study finds that vaccine acceptance is lower than that of non-pharmaceutical intervention life face-mask use and that higher awareness of COVID19 related information and higher household income are correlated with lower vaccine hesitancy.
Journal ArticleDOI
Study on the Refusal of Vaccination against COVID-19 in Romania
TL;DR: In this article , a sociological analysis revealed that 81% of the respondents trust the mandatory vaccines under the national scheme and 57.3% trust the optional ones other than the anti-COVID-19 vaccines (like Rotavirus, Hepatitis A and B, Influenza, Meningococcal, Pneumococcal etc.).
References
More filters
Journal ArticleDOI
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science.
Emily A. Holmes,Emily A. Holmes,Rory C. O'Connor,V. Hugh Perry,Irene Tracey,Simon Wessely,Louise Arseneault,Clive Ballard,Helen Christensen,Roxane Cohen Silver,Ian P. Everall,Tamsin Ford,Ann John,Thomas Kabir,Kate King,Ira Madan,Susan Michie,Andrew K. Przybylski,Roz Shafran,Angela Sweeney,Carol M. Worthman,Lucy Yardley,Katherine Cowan,Claire Cope,Matthew Hotopf,Edward T. Bullmore +25 more
TL;DR: There is an urgent need for research to address how mental health consequences for vulnerable groups can be mitigated under pandemic conditions, and on the impact of repeated media consumption and health messaging around COVID-19.
Journal ArticleDOI
Covid-19: risk factors for severe disease and death.
TL;DR: A long list is emerging from largely unadjusted analyses, with age near the top of the list of top 10 causes of death in the world of sport.
Journal ArticleDOI
Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases
TL;DR: Although some clinicians have discontinued or have considered discontinuing their provider relationship with patients who refuse vaccines, the American Academy of Pediatrics Committee on Bioethics recommends that clinicians address vaccine refusal by respectfully listening to parental concerns and discussing the risks of nonvaccination.
Journal ArticleDOI
A strategic approach to COVID-19 vaccine R&D.
TL;DR: The ACTIV (Accelerating COVID-19 Therapeutic Interventions and Vaccines) public-private partnership brings together the strengths of all sectors at this time of global urgency and a collaborative platform for conducting harmonized, randomized controlled vaccine efficacy trials is discussed.